These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18712769)

  • 1. Combination of immunohistochemistry and laser ablation ICP mass spectrometry for imaging of cancer biomarkers.
    Seuma J; Bunch J; Cox A; McLeod C; Bell J; Murray C
    Proteomics; 2008 Sep; 8(18):3775-84. PubMed ID: 18712769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplexed immunohistochemical detection of tumor markers in breast cancer tissue using laser ablation inductively coupled plasma mass spectrometry.
    Giesen C; Mairinger T; Khoury L; Waentig L; Jakubowski N; Panne U
    Anal Chem; 2011 Nov; 83(21):8177-83. PubMed ID: 21923169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of HER2 receptor status in breast cancer tissues by MALDI imaging mass spectrometry.
    Rauser S; Marquardt C; Balluff B; Deininger SO; Albers C; Belau E; Hartmer R; Suckau D; Specht K; Ebert MP; Schmitt M; Aubele M; Höfler H; Walch A
    J Proteome Res; 2010 Apr; 9(4):1854-63. PubMed ID: 20170166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioimaging of metals by laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).
    Becker JS; Zoriy M; Matusch A; Wu B; Salber D; Palm C; Becker JS
    Mass Spectrom Rev; 2010; 29(1):156-75. PubMed ID: 19557838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synergy of elemental and biomolecular mass spectrometry: new analytical strategies in life sciences.
    Becker JS; Jakubowski N
    Chem Soc Rev; 2009 Jul; 38(7):1969-83. PubMed ID: 19551177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging of uranium on rat brain sections using laser ablation inductively coupled plasma mass spectrometry: a new tool for the study of critical substructures affined to heavy metals in tissues.
    Becker JS; Dobrowolska J; Zoriy M; Matusch A
    Rapid Commun Mass Spectrom; 2008 Sep; 22(18):2768-72. PubMed ID: 18697227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical proteomics in breast cancer: a review.
    Gast MC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2009 Jul; 116(1):17-29. PubMed ID: 19082706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct identification of proteins from T47D cells and murine brain tissue by matrix-assisted laser desorption/ionization post-source decay/collision-induced dissociation.
    Pevsner PH; Naftolin F; Hillman DE; Miller DC; Fadiel A; Kogus A; Stern A; Samuels HH
    Rapid Commun Mass Spectrom; 2007; 21(3):429-36. PubMed ID: 17216666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of metal-binding proteins separated by non-denaturating gel electrophoresis using matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) and laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS).
    Becker JS; Mounicou S; Zoriy MV; Becker JS; Lobinski R
    Talanta; 2008 Sep; 76(5):1183-8. PubMed ID: 18761175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of differentially expressed proteins in triple-negative breast carcinomas using DIGE and mass spectrometry.
    Schulz DM; Böllner C; Thomas G; Atkinson M; Esposito I; Höfler H; Aubele M
    J Proteome Res; 2009 Jul; 8(7):3430-8. PubMed ID: 19485423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a novel anti-mucin 1 (MUC1) antibody (PankoMab) as a potential diagnostic tool in human ductal breast cancer; comparison with two established antibodies.
    Dian D; Janni W; Kuhn C; Mayr D; Karsten U; Mylonas I; Friese K; Jeschke U
    Onkologie; 2009 May; 32(5):238-44. PubMed ID: 19420969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic significance of metalloproteases and their inhibitors in luminal A and basal-like phenotypes of breast carcinoma.
    González LO; Corte MD; Junquera S; González-Fernández R; del Casar JM; García C; Andicoechea A; Vázquez J; Pérez-Fernández R; Vizoso FJ
    Hum Pathol; 2009 Sep; 40(9):1224-33. PubMed ID: 19439346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping of titanium particles in peri-implant oral mucosa by laser ablation inductively coupled plasma mass spectrometry and high-resolution optical darkfield microscopy.
    Flatebø RS; Høl PJ; Leknes KN; Kosler J; Lie SA; Gjerdet NR
    J Oral Pathol Med; 2011 May; 40(5):412-20. PubMed ID: 20969628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Femtosecond laser ablation inductively coupled plasma mass spectrometry: fundamentals and capabilities for depth profiling analysis.
    Pisonero J; Günther D
    Mass Spectrom Rev; 2008; 27(6):609-23. PubMed ID: 18636536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomics-based identification of alpha1-antitrypsin and haptoglobin precursors as novel serum markers in infiltrating ductal breast carcinomas.
    Hamrita B; Chahed K; Trimeche M; Guillier CL; Hammann P; Chaïeb A; Korbi S; Chouchane L
    Clin Chim Acta; 2009 Jun; 404(2):111-8. PubMed ID: 19306859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surface-enhanced Raman scattering imaging of HER2 cancer markers overexpressed in single MCF7 cells using antibody conjugated hollow gold nanospheres.
    Lee S; Chon H; Lee M; Choo J; Shin SY; Lee YH; Rhyu IJ; Son SW; Oh CH
    Biosens Bioelectron; 2009 Mar; 24(7):2260-3. PubMed ID: 19056254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of TRAK1 (Trafficking protein, kinesin-binding 1) as MGb2-Ag: a novel cancer biomarker.
    Zhang F; Ren G; Lu Y; Jin B; Wang J; Chen X; Liu Z; Li K; Nie Y; Wang X; Fan D
    Cancer Lett; 2009 Feb; 274(2):250-8. PubMed ID: 18986759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker discovery in low-grade breast cancer using isobaric stable isotope tags and two-dimensional liquid chromatography-tandem mass spectrometry (iTRAQ-2DLC-MS/MS) based quantitative proteomic analysis.
    Bouchal P; Roumeliotis T; Hrstka R; Nenutil R; Vojtesek B; Garbis SD
    J Proteome Res; 2009 Jan; 8(1):362-73. PubMed ID: 19053527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry.
    Kang S; Maeng H; Kim BG; Qing GM; Choi YP; Kim HY; Kim PS; Kim Y; Kim YH; Choi YD; Cho NH
    J Proteome Res; 2012 Sep; 11(9):4567-74. PubMed ID: 22894699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.